Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Pfizer historical data, for real-time data please try another search
31.20 -0.10    -0.32%
05/10 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
S/N:  852009
  • Volume: 35
  • Bid/Ask: 31.20 / 31.40
  • Day's Range: 31.20 - 31.20
Pfizer 31.20 -0.10 -0.32%

PFE Income Statement

 
Featured here, the Income Statement (earnings report) for Pfizer Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2015
29/06
2015
29/03
2014
31/12
2014
28/09
Total Revenue 11853 10864 13118 12361
Revenue 11853 10864 13118 12361
Other Revenue, Total - - - -
Cost of Revenue, Total 2163 1829 2685 2355
Gross Profit 9690 9035 10433 10006
Total Operating Expenses 8174 7701 11215 8621
Selling/General/Admin. Expenses, Total 3386 3104 3981 3556
Research & Development 1734 1885 3209 1802
Depreciation / Amortization 872 940 949 972
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) 290 170 531 265
Other Operating Expenses, Total -271 -227 -140 -329
Operating Income 3679 3163 1903 3740
Interest Income (Expense), Net Non-Operating -159 -256 -121 -205
Gain (Loss) on Sale of Assets 19 175 21 53
Other, Net - - - -1
Net Income Before Taxes 3539 3082 1803 3587
Provision for Income Taxes 905 706 545 911
Net Income After Taxes 2634 2376 1258 2676
Minority Interest -9 -6 -7 -6
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 2625 2370 1251 2670
Total Extraordinary Items 1 5 -22 -3
Net Income 2626 2375 1229 2667
Total Adjustments to Net Income - - -1 -1
Income Available to Common Excluding Extraordinary Items 2625 2370 1250 2669
Dilution Adjustment - - - -
Diluted Net Income 2626 2375 1228 2666
Diluted Weighted Average Shares 6243 6292 6373 6403
Diluted EPS Excluding Extraordinary Items 0.42 0.38 0.2 0.42
DPS - Common Stock Primary Issue 0.28 0.28 0.26 0.26
Diluted Normalized EPS 0.45 0.37 0.28 0.45
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email